Table 3 Odds ratio for MetS components in relation to hs-CRP and uric acid level
MetS components | Non-elevated hs-CRP, N = 25 | Elevated hs-CRP, N = 100 | Uric acid <6 mg/dL, N = 55 | Uric acid ≥6 mg/dL, N = 70 | Non-elevated hs-CRP and uric acid <6 mg/dL, n = 14 | Non-elevated hs-CRP and uric acid ≥6 mg/dL, N = 11 | Elevated hs-CRP and uric acid <6 mg/dL, n = 41 | Elevated hs-CRP and uric acid ≥6 mg/dL, n = 59 |
|---|---|---|---|---|---|---|---|---|
Raised BP | 17 (68 %) | 78 (78 %) | 39 (70.9 %) | 56 (80 %) | 10 (71.4 %) | 7 (63.6 %) | 29 (70.7 %) | 49 (83 %) |
OR (95 % CI) | 1 (reference) | 1.668 (0.636–4.377, p = 0.304) | 1 (reference) | 1.641 (0.719–3.747, p = 0.293) | 1 (reference) | 0.7 (0.129–3.791, p = 1.0) | 0.967 (0.253–3.694, p = 1.0) | 1.96 (0.511–7.517, p = 0.449) |
Raised glucose | 15 (60 %) | 75 (75 %) | 34 (61.8 %) | 56 (80 %) | 4 (28.5 %) | 11 (100 %) | 30 (73.1 %) | 45 (76.2 %) |
OR (95 % CI) | 1 (reference) | 2.0 (0.798–5.015, p = 0.144) | 1 (reference) | 2.471 (1.111–5.495, p = 0.029) | 1 (reference) | – | 6.818 (1.768–26.294, p = 0.005) | 8.036 (2.178–29.647, p = 0.001) |
Hypertriglyceridemia | 20 (80 %) | 80 (80 %) | 44 (80 %) | 56 (80 %) | 13 (92.8 %) | 7 (63.6 %) | 31 (75.6 %) | 49 (83 %) |
OR (95 % CI) | 1 (reference) | 1.0 (0.334–2.991, p = 1) | 1 (reference) | 1.0 (0.414–2.418, p = 1.0) | 1 (reference) | 0.135 (0.013–1.449, p = 0.133) | 0.238 (0.028–2.058, p = 0.255) | 0.377 (0.044–3.219, p = 0.679) |
Low HDL | 2 (8 %) | 41 (41 %) | 18 (32.7 %) | 25 (35.7 %) | 2 (14.2 %) | – | 16 (39 %) | 25 (42.3 %) |
OR (95 % CI) | 1 (reference) | 7.992 (1.785–35.774, p = 0.002) | 1 (reference) | 1.142 (0.542–2.408, p = 0.85) | 1 (reference) | – | 3.84 (0.758–19.465, p = 0.11) | 4.412 (0.906–21.494, p = 0.067) |